Strategy
|
Strategy: Puzzling PDS off-take
|
|
TPDS covers around a third of Indian households; Food Security will up it to two-thirds
|
|
TPDS off-take is now 51 mn tons; far higher than the 30 mn tons requirement
|
|
Decentralized procurement show meaningful delta; counts as TPDS off-take
|
|
If TPDS consumes 51 mn tons, what estimate should we build for Food Security ordinance?
|
|
Daily Alerts
|
Results
|
Coal India: Mixed bag
|
|
Lower e-auction realizations offset by savings in employee and OBR costs
|
|
Volume growth rather muted, e-auction prices suppress overall realizations
|
|
Maintain BUY with a revised target price of Rs370
|
|
IDEA: We raise estimates, target price; dilution concerns overdone. BUY
|
|
First things first - is the potential equity dilution a cause for concern?
|
|
Business in solid shape; reiterate BUY
|
|
Bharat Heavy Electricals: Weak quarter, bad patch may continue
|
|
Very weak numbers - revenue down 24% yoy, margins (4.5%); PAT halves
|
|
Backlog falls on weak inflows, cancellation; cites potential 15 GW visibility for FY2014
|
|
We revise estimates; reiterate SELL with a target price of Rs140
|
|
Godrej Consumer Products: Profitability elusive, yet again
|
|
1QFY14: Strong domestic show continues, IBD margins drop
|
|
Higher A&SP in domestic business, volatile IBD margins hurt profits
|
|
We retain our REDUCE rating, will revisit numbers after the concall
|
|
Reliance Communications: Fundamentals stressed despite RPM increase; retain SELL
|
|
Business turnaround looks difficult
|
|
Cut consolidated estimates and retain SELL rating
|
|
Grasim Industries: When it rains, it pours
|
|
Weak operating performance across segments - VSF and cement; lower taxes save the day
|
|
Sharp realization decline in both VSF and chemicals leads to 25-30% decline in operating profits
|
|
Maintain ADD rating with TP of Rs3,000
|
|
GlaxoSmithkline Consumer: Good quarter but not good enough to justify the rich valuations
|
|
Marginally below estimates, margin contraction continues (partially hit by one-offs)
|
|
Domestic revenues up 18%; 7% volume growth, 10% price-led growth
|
|
We retain SELL while raising our TP to Rs3,900 (from Rs3,500 earlier)
|
|
Sun TV Network: Steady core business, priced in
|
|
Ad rate hike key driver; market share losses, IPL franchise, cost inflation are risks
|
|
We retain REDUCE with 12-month forward fair value of Rs440 (Rs400 previously); limited upside
|
|
Siemens: All industrials sector bets seem to be off; Siemens just another cog
|
|
Weak results across all segments: EBITDA margin nil, net loss Rs488 mn
|
|
Provisioning continues (may be recovered on contract completion)
|
|
Weak outlook; focus on internal cost cuts as low volumes, pricing, delays, volatility bite
|
|
We revise estimates; SELL on expensive valuations even on optimistic estimates (build significant recovery)
|
|
Cummins India: Weak domestic can possibly accentuate; hopeful on exports, but elusive so far
|
|
Domestic: Cyclical weakness may persist; structural correction in deficit demand has just started
|
|
Exports: Weak global demand scenario overshadows upside risk from LHP scale-up
|
|
Margin downside can come with pricing weakness; inadequate capex compensation sours
|
|
Revise estimates on sharp cuts to sales and margin assumptions; retain REDUCE
|
|
Canara Bank: Margin pressure likely to continue
|
|
Growth focus continues; maintain REDUCE
|
|
Loan impairment ratios remain high; high pipeline of restructured loans
|
|
J&K Bank: Fresh impairments remain high
|
|
Weak performance on loan impairment continues; maintain REDUCE
|
|
Fresh restructuring high; NPL trend stable
|
|
Bajaj Corp.: Good quarter; reiterate BUY
|
|
Another solid quarter in challenging macro, volumes surprise positively (aided by promotions)
|
|
OPM flat despite higher GMs owing to higher A&SP
|
|
Other key highlights from the result
|
|
Results, Change in Reco
|
PFC: Earnings on track, upgrade on inexpensive valuations
|
|
Core earnings growth up 33% yoy, PAT up 23% yoy
|
|
Revision in estimates; upgrade on inexpensive valuations
|
|
Divi's Laboratories: Risk-reward turns favorable, recovery may still take time
|
|
Weak quarter, on expected lines
|
|
Additional units to be commissioned in 2HFY14 - recovery expected in FY2015
|
|
Upgrade to ADD (from REDUCE) with TP at Rs1,040 (from Rs1,060 earlier)
|
|
Oriental Bank of Commerce: The devil is in the price
|
|
Impairment ratios stable - trend similar to previous years in 1Q
|
|
Recent correction gives comfort and management actions positive; upgrade to ADD
|
|
NIM shows a marginal improvement to 2.9% qoq; expect pressure in the short term
|
|
Company alerts
|
Sterlite Industries: Performance contingent on smooth transition in zinc businesses
|
|
Zinc India - 2014 to mark transition to underground mining, open pit ore to fall 22%
|
|
Zinc India - lower ore mining at open cast results in higher strip ratio, maintains cost guidance
|
|
Zinc International - volumes may decline 40% in next 2-3 years unless Gamsberg commences
|
|
Glenmark Pharmaceuticals: Limited comfort on earnings quality
|
|
Emerging markets deliver; US recovery expected in 2QFY14
|
|
No change to guidance
|
|
Maintain cautious view with unchanged TP at Rs535
|
|
Jubilant Foodworks: SSG decelerates further; recovery optimism could be tested
|
|
1QFY14 - growth decelerates top to bottom
|
|
Aggressive store expansion continued
|
|
We like the long-term potential but valuations keep us from turning positive on the stock
|
|
MCX India: When it rains, it pours
|
|
What is NSEL and what happened to it over the past two weeks?
|
|
No comments:
Post a Comment